Serina Tokita

Loss of tapasin in human lung and colon cancer cells and escape from tumor-associated antigen-specific CTL recognition

Yosuke Shionoya, Takayuki Kanaseki, Sho Miyamoto et al. · OncoImmunology · 2017 · 63 citations · Full text

Randomized phase <scp>II</scp> trial of survivin 2B peptide vaccination for patients with <scp>HLA</scp>‐A24‐positive pancreatic adenocarcinoma

Hiroaki Shima, Giichiro Tsurita, Satoshi Wada et al. · Cancer Science · 2019 · 54 citations · Full text

Peptide Vaccination, Immunodeficiencies, Vaccination Therapy +22

The Antigen ASB4 on Cancer Stem Cells Serves as a Target for CTL Immunotherapy of Colorectal Cancer

Sho Miyamoto, Vitaly Kochin, Takayuki Kanaseki et al. · Cancer Immunology Research · 2018 · 49 citations

HLA-A24 ligandome analysis of colon and lung cancer cells identifies a novel cancer-testis antigen and a neoantigen that elicits specific and strong CTL responses

Vitaly Kochin, Takayuki Kanaseki, Serina Tokita et al. · OncoImmunology · 2017 · 35 citations · Full text

CD8+ T–cell Immune Surveillance against a Tumor Antigen Encoded by the Oncogenic Long Noncoding RNA <i>PVT1</i>

Yasuhiro Kikuchi, Serina Tokita, Tomomi Hirama et al. · Cancer Immunology Research · 2021 · 34 citations · Full text